FDA Approvals in Oncology: October-December 2025
In the last quarter of 2025, the FDA announced 20 approvals in oncology, including treatments for lung cancer, multiple...
In the last quarter of 2025, the FDA announced 20 approvals in oncology, including treatments for lung cancer, multiple...
At the AACR Annual Meeting 2025, a session on artificial intelligence in cancer care included ways of detecting skin...
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...
Melanoma is an aggressive form of skin cancer. While it is less common than skin cancers like basal cell...
Skin cancer is the most commonly diagnosed cancer in the United States. Every year, about 5 million Americans are...
Before you try to banish the winter blues by adding some color to your skin with a trip to...
With warm weather finally here, bringing more people outdoors, it is important to remember that many cases of skin...
Immunotherapy was one of the hottest topics at last year’s AACR Annual Meeting, and this year the trend is...
Last week, the U.S. Food and Drug Administration (FDA) approved a new anticancer therapeutic called sonidegib (Odomzo) for patients...
Benjamin Franklin once said, “An ounce of prevention is worth a pound of cure.” While Franklin was referring to...